A generic-mifepristone maker sued the US
The lawsuit by
GenBioPro makes most of the mifepristone sold in the US. It says in its suit that if the FDA is forced to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
